- Agilon Health (AGL) Q1 Earnings and Revenues Top Estimates
May 6, 2026
Agilon Health (AGL) came out with quarterly earnings of $1.8 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +58.73%. A quarter ago, it was expected that this senior-focused health care company would post a loss of $6.75 per share when it actually produced a loss of $11.5, delivering a surprise of -70.37%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Agilon, which belongs to the Zacks Medical Services industry, posted revenues of $1.42 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 3.28%. This compares to year-ago revenues of $1.53 billion. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Agilon shares have added about 55.3% since the beginning of the year versus the S&P 500's gain of 6%.
What's Next for Agilon?
While Agilon has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Agilon was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$1.44 on $1.33 billion in revenues for the coming quarter and -$6.36 on $5.45 billion in revenues for the current fiscal year.
Story Continues
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical Services is currently in the top 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Ascend Wellness Holdings, Inc. (AAWH), another stock in the same industry, has yet to report results for the quarter ended March 2026. The results are expected to be released on May 13.
This company is expected to post quarterly loss of $0.13 per share in its upcoming report, which represents a year-over-year change of -44.4%. The consensus EPS estimate for the quarter has been revised 3.9% higher over the last 30 days to the current level.
Ascend Wellness Holdings, Inc.'s revenues are expected to be $114.2 million, down 10.8% from the year-ago quarter.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Agilon Health, Inc. (AGL) : Free Stock Analysis Report
Ascend Wellness Holdings, Inc. (AAWH) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
View Comments
- Analysts Estimate Ascend Wellness Holdings, Inc. (AAWH) to Report a Decline in Earnings: What to Look Out for
May 6, 2026 · zacks.com
Ascend Wellness Holdings, Inc. (AAWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Revvity (RVTY) Q1 Earnings and Revenues Top Estimates
May 5, 2026
Revvity (RVTY) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $1.01 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +4.10%. A quarter ago, it was expected that this maker of scientific instruments would post earnings of $1.63 per share when it actually produced earnings of $1.7, delivering a surprise of +4.29%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Revvity, which belongs to the Zacks Medical Services industry, posted revenues of $711.12 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 0.85%. This compares to year-ago revenues of $664.76 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Revvity shares have lost about 10.6% since the beginning of the year versus the S&P 500's gain of 5.2%.
What's Next for Revvity?
While Revvity has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Revvity was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.28 on $742.53 million in revenues for the coming quarter and $5.39 on $2.98 billion in revenues for the current fiscal year.
Story Continues
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical Services is currently in the top 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Ascend Wellness Holdings, Inc. (AAWH), is yet to report results for the quarter ended March 2026. The results are expected to be released on May 13.
This company is expected to post quarterly loss of $0.13 per share in its upcoming report, which represents a year-over-year change of -44.4%. The consensus EPS estimate for the quarter has been revised 3.9% higher over the last 30 days to the current level.
Ascend Wellness Holdings, Inc.'s revenues are expected to be $114.2 million, down 10.8% from the year-ago quarter.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Revvity Inc. (RVTY) : Free Stock Analysis Report
Ascend Wellness Holdings, Inc. (AAWH) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
View Comments
- Ascend Wellness Holdings, Inc. (AAWH) Shareholder/Analyst Call Prepared Remarks Transcript
Apr 29, 2026 · seekingalpha.com
Ascend Wellness Holdings, Inc. (AAWH) Shareholder/Analyst Call Prepared Remarks Transcript
- AWH to Hold First Quarter 2026 Earnings Conference Call on Wednesday, May 13, 2026
Apr 29, 2026 · prnewswire.com
NEW YORK, April 29, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U) (OTCQX: AAWH), a leading, multi-state, vertically integrated cannabis operator and consumer packaged goods company, today announced that it will hold a conference call on Wednesday, May 13, 2026, at 5:00 p.m. ET following the release of its first quarter 2026 financial results.
- AWH TO HOLD FIRST QUARTER 2026 EARNINGS CONFERENCE CALL ON WEDNESDAY, MAY 13, 2026
Apr 29, 2026
NEW YORK, APRIL 29, 2026 /PRNEWSWIRE/ - ASCEND WELLNESS HOLDINGS, INC. ("AWH", "ASCEND" OR THE "COMPANY") (CSE: AAWH-U) (OTCQX: AAWH), A LEADING, MULTI-STATE, VERTICALLY INTEGRATED CANNABIS OPERATOR AND CONSUMER PACKAGED GOODS COMPANY, TODAY ANNOUNCED THAT IT WILL HOLD A CONFERENCE CALL ON WEDNESDAY, MAY 13, 2026, AT 5:00 P.M. ET FOLLOWING THE RELEASE OF ITS FIRST QUARTER 2026 FINANCIAL RESULTS.
- Cannabis MSOs to see increased investment, lower taxes from reclassification
Apr 23, 2026
[Background from marijuana plants. Hemp leaves and seeds. Legalization of marijuana, Drug factory,]
Dmytro Skrypnykov/iStock via Getty Images
Cannabis multi-state operators, which surged Wednesday following a report that marijuana would be reclassified [https://seekingalpha.com/news/4577995-marijuana-msos-surge-report-trump-set-to-formally-reclassify-cannabis] as a Schedule III substance, are poised to benefit from increased capital investment and lower taxes, according to an industry insider close to one MSO.
The individual, who requested anonymity, told Seeking Alpha that the official announcement [https://seekingalpha.com/news/4578646-pot-stocks-rise-trump-reschedules-marijuana] earlier today and final order from the Justice Department have been "50 years in the making" and will have many positive impacts on companies in the space.
Because marijuana was classified as a Schedule I substance before—meaning it has no recognized medical benefits and a significant risk of abuse—many institutional investors steered clear of investing in MSOs. But that could soon change, the insider said.
The person said the investment landscape before the announcement had been "a desert with no buyers."
The individual also highlighted tax breaks cannabis businesses will now be eligible for with the reclassification. Section 280E of the tax code, which prohibits companies engaged in the trafficking of Schedule I or II substances from deducting business expenses, will no longer apply to MSOs.
It is important to note that the reclassification does not mean marijuana is legalized on the federal level. Penalties still exist on the federal level for possession and distribution, though as a Schedule III, they are less than for a Schedule I drug.
The move will also allow further research into marijuana's medical benefits.
While other observers cheered the reclassification, they noted that other changes are needed before more significant benefits for the industry can be achieved.
The "final order to place certain cannabis-related products in Schedule III marks a meaningful, but highly targeted, policy shift," FundCanna [https://fundcanna.com/] CEO Adam Stettner said in a statement. "Rather than broadly rescheduling cannabis, the order applies specifically to FDA-approved cannabis drugs and products operating under state medical marijuana frameworks, reinforcing that federal recognition is advancing but not yet universal across the industry."
Multi-state operators: Ascend Wellness (OTCQX:AAWH [https://seekingalpha.com/symbol/AAWH#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]), Curaleaf Holdings (OTCPK:CURLF [https://seekingalpha.com/symbol/CURLF#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]), Cresco Labs (OTCQX:CRLBF [https://seekingalpha.com/symbol/CRLBF#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]), Green Thumb Industries (OTCQX:GTBIF [https://seekingalpha.com/symbol/GTBIF#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]), Trulieve Cannabis (OTCQX:TCNNF [https://seekingalpha.com/symbol/TCNNF#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]), Ayr Wellness (OTCQX:AYRWF [https://seekingalpha.com/symbol/AYRWF#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]), Verano Holdings (VRNO [https://seekingalpha.com/symbol/VRNO]), and Jushi Holdings (OTCQX:JUSHF [https://seekingalpha.com/symbol/JUSHF#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]).
Canadian cannabis LPs: Canopy Growth (CGC [https://seekingalpha.com/symbol/CGC]), Tilray Brands (TLRY [https://seekingalpha.com/symbol/TLRY]), Cronos (CRON), Aurora Cannabis (ACB), SNDL (SNDL), and OrganiGram Holdings (OGI).
Cannabis ETFs: AdvisorShares Pure Cannabis ETF (NYSEARCA:YOLO [https://seekingalpha.com/symbol/YOLO#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]), Amplify Alternative Harvest ETF (MJUS [https://seekingalpha.com/symbol/MJUS]), and Amplify Seymour Cannabis ETF (NYSEARCA:CNBS [https://seekingalpha.com/symbol/CNBS#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]).
Cannabis REITs: Innovative Industrial Properties (IIPR [https://seekingalpha.com/symbol/IIPR]), New Lake Capital Partners (NLCP [https://seekingalpha.com/symbol/NLCP]).
MORE ON MULTI-STATE OPERATORS
* Green Thumb's 280E Gamble [https://seekingalpha.com/article/4893247-green-thumbs-280e-gamble]
* Trulieve Cannabis: Preparing For Rescheduling [https://seekingalpha.com/article/4893065-trulieve-cannabis-preparing-for-rescheduling]
* Cresco Labs Will Remain Undervalued Without Any New Synergies (Rating Downgrade) [https://seekingalpha.com/article/4882565-cresco-labs-stock-will-remain-undervalued-without-new-synergies]
* Green Thumb expands buyback program by $100M [https://seekingalpha.com/news/4578581-green-thumb-expands-buyback-program-by-100m]
* Quant snapshot on cannabis names as Trump plans reclassification [https://seekingalpha.com/news/4578391-quant-snapshot-on-cannabis-names-as-trump-plans-reclassification]
- Ascend Wellness Holdings Announces the Opening of East Coasting Dispensary in Eatontown, New Jersey
Apr 22, 2026 · prnewswire.com
Independent Adult-Use Dispensary Established with Cannabis Reform Advocate Kyle Page NEW YORK, April 22, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a leading, multi-state, vertically integrated cannabis operator and consumer packaged goods company, today announced the opening of East Coasting, a new adult-use cannabis dispensary located at 178 NJ-35 Eatontown, NJ. Through a partnership agreement under New Jersey law that facilitates expanded investment opportunities for diversely-owned businesses in the cannabis industry, East Coasting will operate independently, with Ascend providing operational support and resources along with cannabis reform advocate Kyle Page.
- ASCEND WELLNESS HOLDINGS ANNOUNCES THE OPENING OF EAST COASTING DISPENSARY IN EATONTOWN, NEW JERSEY
Apr 22, 2026
INDEPENDENT ADULT-USE DISPENSARY ESTABLISHED WITH CANNABIS REFORM ADVOCATE KYLE PAGE NEW YORK, APRIL 22, 2026 /PRNEWSWIRE/ - ASCEND WELLNESS HOLDINGS, INC. ("AWH," "ASCEND," OR THE "COMPANY") (CSE: AAWH.U) (OTCQX: AAWH), A LEADING, MULTI-STATE, VERTICALLY INTEGRATED CANNABIS OPERATOR AND CONSUMER PACKAGED GOODS COMPANY, TODAY ANNOUNCED THE OPENING OF EAST COASTING, A NEW ADULT-USE CANNABIS DISPENSARY LOCATED AT 178 NJ-35 EATONTOWN, NJ. THROUGH A PARTNERSHIP AGREEMENT UNDER NEW JERSEY LAW THAT FACILITATES EXPANDED INVESTMENT OPPORTUNITIES FOR DIVERSELY-OWNED BUSINESSES IN THE CANNABIS INDUSTRY, EAST COASTING WILL OPERATE INDEPENDENTLY, WITH ASCEND PROVIDING OPERATIONAL SUPPORT AND RESOURCES ALONG WITH CANNABIS REFORM ADVOCATE KYLE PAGE.
- 3 Top Marijuana Stocks For Better Trading And Investing
Apr 8, 2026 · marijuanastocks.com
Most marijuana stocks are still trading at low price points. There are several reasons for this, and what adds to and creates volatility and speculation. When a company reports strong earnings or significant news, it can significantly impact how its stock trades. The outlook for the future is where many believe the turning point will be for investors to achieve sizable gains. In the USA, more states are working on passing cannabis reform.
